Nitika Pharmaceutical Specialities Private Limited, a active private limited company, was established on 12 March 2011 in Nagpur, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230MH2011PTC214662. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹9.50 Cr and a paid-up capital of ₹3.14 Cr.
Formerly known as Nitika Pharma Specialities Private Limited. It upholds a compliant status. Employing 122 professional, Its leadership includes Ravleen Singh Khurana (Director), Manojkumar Badrinarayan Agrawal (Director), Parvinder Singh (Director). Past directors included Manojkumar Badrinarayan Agrawal, Parvinder Singh, Mangesh Eknath Bhad. It holds ₹180.53 Cr open charges and ₹20.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Fortune Ritz, F. No. 101, Pl. 240/A,, Near Raja Rani Square, Civil Lines,, Nagpur, Maharashtra, 440001.
U24230MH2011PTC214662
214662
12 March 2011
₹9.50 Cr
₹3.14 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nitika Pharmaceutical Specialities Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravleen Singh Khurana | Director | 12 Mar 2011 | Current |
| Manojkumar Badrinarayan Agrawal | Director | 10 Jul 2018 | Current |
| Parvinder Singh | Director | 11 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 31 Jul 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2022 | Past |
| Pramod Abcsdd | Director | 13 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nitika Pharmaceutical Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.44% increase. The company also saw a slight improvement in profitability, with a 2.39% increase in profit. The company's net worth Soared by an impressive increase of 20.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nitika Pharmaceutical Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,805,276,727.00
₹207,670,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2025 | Bank Of India | ₹3.00 Cr | Open |
| 30 May 2025 | Others | ₹100.00 Cr | Open |
| 12 Dec 2023 | Bank Of India | ₹35.00 Cr | Open |
| 22 Mar 2022 | Axis Bank Limited | ₹42.19 Cr | Open |
| 27 Nov 2020 | Hdfc Bank Limited | ₹3.40 M | Open |
Explore comprehensive loan charge details -
Nitika Pharmaceutical Specialities has a workforce of 122 employees as of Dec 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nitika Pharmaceutical Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitika Pharmaceutical Specialities's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Bank Of India amounted to Rs. 3.00 Cr with Charge ID 101130521 was registered on 16 Jul 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101107432 was registered on 30 May 2025. was recorded as a recent event.
Progress on A charge registered on 20 May 2023 via Charge ID 100729002 with Bank Of India was fully satisfied on 07 May 2025. was documented.
Progress on Nitika Pharmaceutical Specialities Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Nitika Pharmaceutical Specialities Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 28 Mar 2012 via Charge ID 10350851 with Bank Of India was fully satisfied on 15 Mar 2024. was completed.
The CIN of Nitika Pharmaceutical Specialities Private Limited is U24230MH2011PTC214662.
Nitika Pharmaceutical Specialities Private Limited is headquartered at Fortune Ritz, F. No. 101, Pl. 240/A,, Near Raja Rani Square, Civil Lines,, Nagpur, Maharashtra, 440001.
Nitika Pharmaceutical Specialities Private Limited was incorporated on 12 March 2011.
The current directors of Nitika Pharmaceutical Specialities Private Limited are
The primary industry of Nitika Pharmaceutical Specialities Private Limited is Manufacturing.
Nitika Pharmaceutical Specialities Private Limited is unlisted.
The authorized capital of Nitika Pharmaceutical Specialities Private Limited is ₹9.50 Cr, and the paid-up capital is ₹3.14 Cr.
The compliance status of Nitika Pharmaceutical Specialities Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX